Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

EGRX Stock Forecast, Price Targets, Chart, Dividends & Analysis

Eagle Pharmaceuticals Inc. logo

Eagle Pharmaceuticals Inc.

Sector: Healthcare   

Industry: Drug Manufacturers - Specialty & Generic

0.90
 
USD
  
-1.09
  
(-54.78%)
Previous close: 1.99  Open: 1.9  Bid:   Ask:
52 week range    
0.75   
   14.78
Mkt Cap: 46 M  Avg Vol (90 Days): 202,059
Peers   
JNJ / 
GSK / 
NVS / 
TEVA / 
AMGN / 
LLY / 
Last updated: Monday 7th October 2024

Stock Rankings

48
MarketXLS Rank
80
Value
38
Technical
28
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

AMGN

0.0282172 B55.31319.66

BMY

0.0445107 B1453.96

GSK

JNJ

0.0309390 B24.94160.29

LLY

0.0059841 B114.68887.16

NVS

TEVA

Financials

EGRX Income Statement

Annual
Invalid dateSep-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
AccruedPreferredStockDividends-2 M
Amortization of intangibles-948000.0-3 M-3 M3 M3 M40 M45 M
Basic EPS from continuing operations1.040.89-0.662.76
Basic EPS total-1.970.175.243.442.161.040.89-0.662.76
Basic weighted shares outstanding10 M15 M16 M15 M15 M14 M13 M13 M13 M
Cost of sales-5 M-8 M-36 M-34 M-42 M48 M45 M42 M95 M
Depreciation-104000.0-112000.0-641000.0-932000.0-1 M972000.0872000.0764000.0646000.0
DepreciationAndAmortization-104000.0-112000.0-641000.0-932000.0-1 M972000.0872000.0764000.0646000.0
Diluted EPS total-1.970.164.963.272.091.010.87-0.662.73
Diluted normalized net income/share1.010.87-0.662.73
Diluted weighted shares outstanding10 M16 M16 M16 M15 M14 M14 M13 M13 M
GainOnSaleOfPPE2 M
GainOnSaleOfSecurity-5 M-6 M-4 M
GeneralAndAdministrativeExpense2 M-514000.0-1000.0-664000.0-571000.076 M79 M75 M107 M
Gross operating profit7 M58 M154 M203 M171 M148 M142 M129 M222 M
ImpairmentOfCapitalAssets7 M3 M
Income before tax-19 M3 M53 M73 M34 M22 M23 M-5 M61 M
Income restructuring and M&A2 M8 M
Income taxes-1 M3000.0-28 M21 M2 M8 M11 M4 M26 M
Interest income31000.025000.084000.091000.0158000.02 M562000.0560000.0271000.0
InterestExpenseNonOperating8000.011000.08000.01 M3 M3 M3 M2 M4 M
MarketingExpense-3 M-5 M-15 M-18 M-3 M2 M3 M3 M9 M
MiscOtherSpecialCharges-538000.0-300000.0700000.0-8 M-6 M-16 M
Net income from total operations-20 M3 M81 M52 M32 M14 M12 M-9 M36 M
NetIncomeCommonStockholders-20 M3 M81 M52 M32 M14 M12 M-9 M36 M
NetIncomeContinuousOperations-20 M3 M81 M52 M32 M14 M12 M-9 M36 M
NetNonOperatingInterestIncomeExpense23000.014000.076000.0-1 M-3 M-517000.0-2 M-1 M-4 M
NonRecurringOperationExpense2 M
Normalized income-4 M49 M
Operating income-20 M3 M53 M75 M46 M22 M33 M3 M81 M
Operating income before depreciation (EBITDA)-19 M3 M55 M78 M41 M30 M29 M847000.078 M
OperatingExpense-38 M-64 M-136 M-163 M124 M126 M121 M137 M150 M
Other income net538000.0-793000.0-7 M-763000.0-700000.08 M6 M16 M
OtherGandA2 M-514000.0-1000.0-664000.0-571000.076 M79 M75 M107 M
OtherOperatingExpenses-38 M8 M20 M23 M20 M13 M12 M11 M9 M
OtherunderPreferredStockDividend-2 M
PreferredStockDividends-2 M
RentAndLandingFees-277000.0-514000.0-1000.0-664000.0-571000.0
Research & development expense17 M28 M28 M33 M44 M37 M31 M51 M34 M
ResearchExpense17 M28 M28 M33 M44 M37 M31 M51 M34 M
RestructringAndMnAIncome2 M8 M
Revenue per share-948000.0-3 M-3 M3 M3 M40 M45 M
SalariesAndWages-606000.0-4 M-10 M-15 M-19 M
Selling Gen & administrative expense11 M20 M53 M71 M61 M76 M79 M75 M107 M
SellingAndMarketingExpense9 M20 M53 M71 M61 M2 M3 M3 M9 M
SellingExpense9 M20 M53 M71 M61 M
Special income/charges-2 M-9 M-11 M
Total Income available for interest expense (EBIT)-19 M3 M53 M74 M37 M25 M25 M-3 M65 M
Total common shares outstanding14 M16 M15 M15 M14 M14 M13 M13 M13 M
Total net income-20 M3 M81 M52 M32 M14 M12 M-9 M36 M
Total ordinary shares13 M13 M13 M13 M13 M13 M13 M13 M13 M
Total revenues19 M66 M189 M237 M213 M196 M188 M172 M317 M
TotalExpenses-43 M-71 M-172 M-196 M82 M174 M155 M169 M236 M
TotalRevenue5 M13 M41 M237 M213 M196 M188 M172 M317 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University